These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 36992294)
41. Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals. Kuzel TG; Fu J; Anderson M; Stec M; Boler M; Behun D; Gosha A; Cloherty G; Landay A; Moy J Vaccine; 2023 Jan; 41(4):879-882. PubMed ID: 36572601 [TBL] [Abstract][Full Text] [Related]
42. Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets. Verkhivker G; Agajanian S; Kassab R; Krishnan K Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232845 [TBL] [Abstract][Full Text] [Related]
43. Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking. Liu L; Casner RG; Guo Y; Wang Q; Iketani S; Chan JF; Yu J; Dadonaite B; Nair MS; Mohri H; Reddem ER; Yuan S; Poon VK; Chan CC; Yuen KY; Sheng Z; Huang Y; Bloom JD; Shapiro L; Ho DD bioRxiv; 2023 Apr; ():. PubMed ID: 37090592 [TBL] [Abstract][Full Text] [Related]
45. An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo. Ikemura N; Taminishi S; Inaba T; Arimori T; Motooka D; Katoh K; Kirita Y; Higuchi Y; Li S; Suzuki T; Itoh Y; Ozaki Y; Nakamura S; Matoba S; Standley DM; Okamoto T; Takagi J; Hoshino A Sci Transl Med; 2022 Jun; 14(650):eabn7737. PubMed ID: 35471044 [TBL] [Abstract][Full Text] [Related]
46. Long-term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac-inactivated booster: A 7-month follow-up study. Li X; Yin Y; Cui Q; Huang W; Zou Q; Shen T J Med Virol; 2023 Jan; 95(1):e28279. PubMed ID: 36329634 [TBL] [Abstract][Full Text] [Related]
48. Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades. Dadonaite B; Brown J; McMahon TE; Farrell AG; Asarnow D; Stewart C; Logue J; Murrell B; Chu HY; Veesler D; Bloom JD bioRxiv; 2023 Nov; ():. PubMed ID: 38014024 [TBL] [Abstract][Full Text] [Related]
49. Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5. Wang Y; Yan A; Song D; Dong C; Rao M; Gao Y; Qi R; Ma X; Wang Q; Xu H; Liu H; Han J; Duan M; Liu S; Yu X; Zong M; Feng J; Jiao J; Zhang H; Li M; Yu B; Wang Y; Meng F; Ni X; Li Y; Shen Z; Sun B; Shao X; Zhao H; Zhao Y; Li R; Zhang Y; Du G; Lu J; You C; Jiang H; Zhang L; Wang L; Dou C; Liu Z; Zhao J Cell Discov; 2023 Jan; 9(1):3. PubMed ID: 36609558 [TBL] [Abstract][Full Text] [Related]
51. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385 [TBL] [Abstract][Full Text] [Related]
52. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters. Halfmann PJ; Iwatsuki-Horimoto K; Kuroda M; Hirata Y; Yamayoshi S; Iida S; Uraki R; Ito M; Ueki H; Furusawa Y; Sakai-Tagawa Y; Kiso M; Armbrust T; Spyra S; Maeda K; Wang Z; Imai M; Suzuki T; Kawaoka Y Commun Biol; 2024 Mar; 7(1):331. PubMed ID: 38491227 [TBL] [Abstract][Full Text] [Related]
53. An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2. Zhang L; Narayanan KK; Cooper L; Chan KK; Devlin CA; Aguhob A; Shirley K; Rong L; Rehman J; Malik AB; Procko E bioRxiv; 2022 Mar; ():. PubMed ID: 35378764 [TBL] [Abstract][Full Text] [Related]
56. SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization. Mannar D; Saville JW; Sun Z; Zhu X; Marti MM; Srivastava SS; Berezuk AM; Zhou S; Tuttle KS; Sobolewski MD; Kim A; Treat BR; Da Silva Castanha PM; Jacobs JL; Barratt-Boyes SM; Mellors JW; Dimitrov DS; Li W; Subramaniam S Nat Commun; 2022 Aug; 13(1):4696. PubMed ID: 35982054 [TBL] [Abstract][Full Text] [Related]
57. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose. Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I Front Immunol; 2023; 14():1099246. PubMed ID: 36756112 [TBL] [Abstract][Full Text] [Related]
58. A multispecific antibody prevents immune escape and confers pan-SARS-CoV-2 neutralization. Misasi J; Wei RR; Wang L; Pegu A; Wei CJ; Oloniniyi OK; Zhou T; Moliva JI; Zhao B; Choe M; Yang ES; Zhang Y; Boruszczak M; Chen M; Leung K; Li J; Yang ZY; Andersen H; Carlton K; Godbole S; Harris DR; Henry AR; Ivleva VB; Lei P; Liu C; Longobardi L; Merriam JS; Nase D; Olia AS; Pessaint L; Porto M; Shi W; Wolff JJ; Douek DC; Suthar MS; Gall J; Koup RA; Kwong PD; Mascola JR; Nabel GJ; Sullivan NJ bioRxiv; 2022 Nov; ():. PubMed ID: 35982683 [TBL] [Abstract][Full Text] [Related]
59. Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses. Li M; Ren Y; Aw ZQ; Chen B; Yang Z; Lei Y; Cheng L; Liang Q; Hong J; Yang Y; Chen J; Wong YH; Wei J; Shan S; Zhang S; Ge J; Wang R; Dong JZ; Chen Y; Shi X; Zhang Q; Zhang Z; Chu JJH; Wang X; Zhang L Nat Commun; 2022 Dec; 13(1):7957. PubMed ID: 36575191 [TBL] [Abstract][Full Text] [Related]
60. An ACE2-Based Decoy Inhibitor Effectively Neutralizes SARS-CoV-2 Omicron BA.5 Variant. Zhang H; Hu B; Lv P; Liu Y; Guo M; Wu Z; Zhou K; Dai M; Yu X; Liu Z; Yu B; Xu L; Guo M; Cai K; Li Y Viruses; 2022 Oct; 14(11):. PubMed ID: 36366484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]